• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者的视觉注意力

Visual attention in patients with chronic obstructive pulmonary disease.

作者信息

Vos P J, Folgering H T, van Herwaarden C L

机构信息

Department of Pulmonary Diseases, University of Nijmegen, Medical Centre Dekkerswald, Groesbeek, The Netherlands.

出版信息

Biol Psychol. 1995 Nov 16;41(3):295-305. doi: 10.1016/0301-0511(95)05140-6.

DOI:10.1016/0301-0511(95)05140-6
PMID:8608205
Abstract

The selective visual attention of 39 patients with chronic obstructive pulmonary disease (COPD) was measured by the Bourdon-Vos test and compared with the attention performance of 38 healthy controls of the same age range. The correlation between the attention of the COPD patients and day- and night-time parameters was determined. Furthermore, in 44 other COPD patients with daytime hypoxaemia, the effect of one night of oxygen supplementation and of a 7-day treatment with two respiratory stimulants (chlormadinone acetate) (CMA) or acetazolamide (ACET) on attention performance was studied. The results showed that the attention performance of COPD patients was lower than that of controls. Significant correlations were found between the mean line time (attention parameter) and the following parameters: age, inspiratory vital capacity (IVC), hypercapnic ventilatory response (HCVR), daytime arterial oxygen saturation (SaO2), daytime arterial oxygen pressure (PaO2), daytime arterial carbon dioxide pressure (PaCO2), mean nocturnal SaO2, lowest nocturnal SaO2 and the standard deviation of the mean nocturnal SaO2. Multiple linear regression analysis showed that, apart from age, only the nadir of the nocturnal SaO2 contributed to the prediction of the attention. No clinically important short-term effect of oxygen or respiratory stimulating therapy on the attention performance was found.

摘要

采用布尔东-沃斯测试测量了39例慢性阻塞性肺疾病(COPD)患者的选择性视觉注意力,并与38名年龄范围相同的健康对照者的注意力表现进行了比较。确定了COPD患者注意力与昼夜参数之间的相关性。此外,在另外44例白天低氧血症的COPD患者中,研究了一晚吸氧以及使用两种呼吸兴奋剂(醋酸氯地孕酮)(CMA)或乙酰唑胺(ACET)进行7天治疗对注意力表现的影响。结果显示,COPD患者的注意力表现低于对照组。发现平均线时间(注意力参数)与以下参数之间存在显著相关性:年龄、吸气肺活量(IVC)、高碳酸通气反应(HCVR)、白天动脉血氧饱和度(SaO2)、白天动脉血氧分压(PaO2)、白天动脉血二氧化碳分压(PaCO2)、夜间平均SaO2、夜间最低SaO2以及夜间平均SaO2的标准差。多元线性回归分析表明,除年龄外,只有夜间SaO2的最低点有助于预测注意力。未发现吸氧或呼吸刺激疗法对注意力表现有临床上重要的短期影响。

相似文献

1
Visual attention in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的视觉注意力
Biol Psychol. 1995 Nov 16;41(3):295-305. doi: 10.1016/0301-0511(95)05140-6.
2
Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD).醋酸氯地孕酮、乙酰唑胺及氧对慢性阻塞性肺疾病(COPD)患者清醒和睡眠时气体交换的影响。
Eur Respir J. 1994 May;7(5):850-5.
3
Sleep quality, carbon dioxide responsiveness and hypoxaemic patterns in nocturnal hypoxaemia due to chronic obstructive pulmonary disease (COPD) without daytime hypoxaemia.无日间低氧血症的慢性阻塞性肺疾病(COPD)所致夜间低氧血症患者的睡眠质量、二氧化碳反应性及低氧血症模式
Respir Med. 1999 Feb;93(2):79-87. doi: 10.1016/s0954-6111(99)90295-0.
4
Predictors for nocturnal hypoxaemia (mean SaO2 < 90%) in normoxic and mildly hypoxic patients with COPD.慢性阻塞性肺疾病(COPD)的正常氧合和轻度低氧血症患者夜间低氧血症(平均动脉血氧饱和度<90%)的预测因素。
Eur Respir J. 1995 Jan;8(1):74-7. doi: 10.1183/09031936.95.08010074.
5
Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients.乙酰唑胺与甲羟孕酮联合治疗慢性阻塞性肺疾病患者。
Eur Respir J. 2002 Nov;20(5):1130-7. doi: 10.1183/09031936.02.00016402.
6
Nocturnal hypoxaemia in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的夜间低氧血症
Clin Sci (Lond). 1983 Feb;64(2):213-22. doi: 10.1042/cs0640213.
7
Predictors of nocturnal oxygen desaturation in patients with COPD.慢性阻塞性肺疾病患者夜间氧饱和度降低的预测因素
Respir Med. 1999 Mar;93(3):202-7. doi: 10.1016/s0954-6111(99)90009-4.
8
[The impact of different definitions of hypoxemia on the relation between awake pulmonary pressure and hypoxemia during sleep in patients with COPD].[不同低氧血症定义对慢性阻塞性肺疾病患者清醒时肺压与睡眠期间低氧血症关系的影响]
Pneumologie. 2001 Jun;55(6):289-94. doi: 10.1055/s-2001-14677.
9
Nocturnal saturation and respiratory muscle function in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的夜间血氧饱和度及呼吸肌功能
Thorax. 1995 Jun;50(6):610-2. doi: 10.1136/thx.50.6.610.
10
Effect of chlormadinone acetate on ventilatory control in patients with chronic obstructive pulmonary disease.醋酸氯地孕酮对慢性阻塞性肺疾病患者通气控制的影响。
Am Rev Respir Dis. 1986 Apr;133(4):552-7. doi: 10.1164/arrd.1986.133.4.552.

引用本文的文献

1
Visuomotor performance at high altitude in COPD patients. Randomized placebo-controlled trial of acetazolamide.慢性阻塞性肺疾病(COPD)患者在高海拔地区的视运动表现。乙酰唑胺的随机安慰剂对照试验。
Front Physiol. 2022 Sep 8;13:980755. doi: 10.3389/fphys.2022.980755. eCollection 2022.
2
Cognition and chronic hypoxia in pulmonary diseases.肺部疾病中的认知与慢性缺氧
Dement Neuropsychol. 2010 Jan-Mar;4(1):14-22. doi: 10.1590/S1980-57642010DN40100003.
3
Effects of chronic obstructive pulmonary disease and obstructive sleep apnea on cognitive functions: evidence for a common nature.
慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停对认知功能的影响:共同本质的证据
Sleep Disord. 2014;2014:768210. doi: 10.1155/2014/768210. Epub 2014 Feb 6.
4
Executive and attentional functions in chronic pain: does performance decrease with increasing task load?慢性疼痛中的执行和注意功能:随着任务负荷的增加,表现是否会下降?
Pain Res Manag. 2012 May-Jun;17(3):159-65. doi: 10.1155/2012/962786.
5
Behavior Problems in Relation to Sustained Selective Attention Skills of Moderately Preterm Children.中度早产儿的行为问题与持续选择性注意力技能的关系
J Dev Phys Disabil. 2012 Apr;24(2):111-123. doi: 10.1007/s10882-011-9258-9. Epub 2011 Oct 22.
6
Outcomes of dysphagia intervention in a pulmonary rehabilitation program.肺康复计划中吞咽障碍干预的结果。
Dysphagia. 2010 Jun;25(2):104-11. doi: 10.1007/s00455-009-9230-3. Epub 2009 Jul 18.
7
Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病高碳酸血症性通气衰竭的碳酸酐酶抑制剂
Cochrane Database Syst Rev. 2001;2001(1):CD002881. doi: 10.1002/14651858.CD002881.